Search Results for

ICD-10 – Requisition Update

September 28, 2015

In an effort to ensure uninterrupted order processing, clients who submit testing by a standard PathGroup requisition should indicate ICD-10 codes for services performed on and after October 1, 2015.

PathGroup encourages clients to utilize their existing requisition inventory until it has been depleted. Regardless of whether or not a requisition indicates “ICD-9” for diagnosis, clients should provide an ICD-10 code on or after October 1, 2015. PathGroup will accept all existing requisitions provided that the proper ICD-10 code(s) for services is indicated.

Click Here to read more.

ICD-10 – Pap Diagnosis Code Update

September 8, 2015

Effective October 1, 2015, the Centers for Medicare and Medicaid Services (CMS) mandated conversion from the International Classification of Diseases 9th Revision (ICD-9) to the International Classification of Diseases 10th Revision (ICD-10) will go into effect.  A key trait of ICD-10 introduces more specific and complete codes that reflect modern medicine and updated medical terminology. As a result, Pap smear diagnosis codes have expanded for routine and high risk patient visits.

Click Here to read more.

Molecular Oncology – Report Update

This change will take effect August 31, 2015

Overview and Clinical Utility:
Effective August 31, 2015, PathGroup will introduce updated molecular oncology reports with key enhancements to formatting, color blocking and report layout. This release is the combined effort of the Molecular Operations and IT Development teams to bring clients clear concise reports optimized for ease of use and interpretation.

Click Here to read more.

ICD-10 – Implementation Update

July 31, 2015

The conversion from ICD-9 to ICD-10 is quickly approaching and will go into effect on October 1, 2015 – just two months away! PathGroup is working diligently towards implementation and will be equipped to support the new code set come October. PathGroup is actively working to integrate all systems and resources, and encourage our clients to do the same.

Click Here to read more.

OVA1 – Test Update

This change will take effect July 20, 2015

Overview and Clinical Utility:

Effective July 20, 2015, PathGroup will no longer perform testing for OVA1, a proprietary Aspira Labs assay used for the evaluation of ovarian masses. To avoid disruption in services, PathGroup will manage orders for OVA1 testing through a Third Party Phlebotomy Agreement.

Click Here to read more.

Ova and Parasite Stool Collection – Test Update

This change will take effect immediately

Overview and Clinical Utility:

Effective immediately, PathGroup will implement a new single transport system, Parasep® SF Patient Care Pack, for fecal collection and transport of specimens for Ova and Parasite Fecal Examination. The one-vial system, distinguishable by its green cap and AlcorFix contents, will replace the two-vial blue and pink Para-Pak® collection containers.

Click Here to read more.

FibroMeter Testing – Test Update

This change will take effect June 29, 2015

Overview and Clinical Utility:

Effective June 29, 2015 PathGroup Labs will begin offering the non-invasive Echosens FibroMeter diagnostic test for liver fibrosis and inflammation. This addition provides clients with superior testing results and improved turnaround time. In addition to current chemistry assays, FibroMeter utilizes two supplementary tests, platelet count and prothrombin index, to result a fibrosis, cirrhosis, and activity score.

Click Here to read more.

Specimen Stability – Urgent Notice

June 24, 2015

Summer is officially here and temperatures are heating up! PathGroup would like to remind all clients that specimens must be kept from extreme temperatures in order to provide optimal stability and validity for patient results. To preserve specimen stability during the summer months, PathGroup recommends specimens be placed in the lockbox 30 minutes before your scheduled courier pick up or as close to your scheduled pick up time as possible. Purple top tubes for Complete Blood Count (CBC) analysis, in particular, must be kept cool.

Click Here to read more.

ICD-10 – Implementation Update

June 23, 2015

The Centers for Medicare and Medicaid Services (CMS) mandated conversion from the International Classification of Diseases 9th Revision (ICD-9) to the International Classification of Diseases 10th Revision (ICD-10) will go into effect October 1, 2015. Physicians, insurance providers, EHR/EMR vendors, and laboratories are just some of those preparing to implement the new code set. PathGroup is no exception. With the deadline quickly approaching, we are working diligently to facilitate a smooth transition for our clients.

Click Here to read more.